Formulation and Device Lifecycle Management of Biotherapeutics
portes grátis
Formulation and Device Lifecycle Management of Biotherapeutics
A Guidance for Researchers and Drug Developers
Bittner, Beate; Schmidt, Johannes
Elsevier Science Publishing Co Inc
01/2022
228
Mole
Inglês
9780128237410
15 a 20 dias
450
Descrição não disponível.
1. Enabling customer-centric and sustainable drug delivery-formulation and device lifecycle management of biotherapeutics
2. Clinical development of subcutaneous dosing alternatives to established intravenous formulations for monoclonal antibodies-pharmacokinetic-based bridging approach
3. Clinical development of automated subcutaneous injection devices-established pathways and novel concepts
4. Enabling a flexible care setting in oncology-how to realize home- and self-administration of biotherapeutics in cancer care
5. Formulation and device lifecycle management of biotherapeutics-leveraging synergies across therapeutic areas
6. Formulation and device lifecycle management of biotherapeutics-decision architecture
7. Summary and outlook
2. Clinical development of subcutaneous dosing alternatives to established intravenous formulations for monoclonal antibodies-pharmacokinetic-based bridging approach
3. Clinical development of automated subcutaneous injection devices-established pathways and novel concepts
4. Enabling a flexible care setting in oncology-how to realize home- and self-administration of biotherapeutics in cancer care
5. Formulation and device lifecycle management of biotherapeutics-leveraging synergies across therapeutic areas
6. Formulation and device lifecycle management of biotherapeutics-decision architecture
7. Summary and outlook
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Biological medicine; Biopharmaceutical; Biotherapeutics; Drug delivery; Handheld syringe; Healthcare expenditure; Infusion set; Lifecycle management; MAbs; Monoclonal antibodies; Patient-centric product; Prefilled syringe; Subcutaneous formulations; Subcutaneous injection
1. Enabling customer-centric and sustainable drug delivery-formulation and device lifecycle management of biotherapeutics
2. Clinical development of subcutaneous dosing alternatives to established intravenous formulations for monoclonal antibodies-pharmacokinetic-based bridging approach
3. Clinical development of automated subcutaneous injection devices-established pathways and novel concepts
4. Enabling a flexible care setting in oncology-how to realize home- and self-administration of biotherapeutics in cancer care
5. Formulation and device lifecycle management of biotherapeutics-leveraging synergies across therapeutic areas
6. Formulation and device lifecycle management of biotherapeutics-decision architecture
7. Summary and outlook
2. Clinical development of subcutaneous dosing alternatives to established intravenous formulations for monoclonal antibodies-pharmacokinetic-based bridging approach
3. Clinical development of automated subcutaneous injection devices-established pathways and novel concepts
4. Enabling a flexible care setting in oncology-how to realize home- and self-administration of biotherapeutics in cancer care
5. Formulation and device lifecycle management of biotherapeutics-leveraging synergies across therapeutic areas
6. Formulation and device lifecycle management of biotherapeutics-decision architecture
7. Summary and outlook
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
